[en] Neuropilin-1 (NRP1) is a transmembrane protein acting as a co-receptor for several growth factors and interacting with other proteins such as integrins and plexins/semaphorins. It is involved in axonal development, angiogenesis and cancer progression. Its primary mRNA is subjected to alternative splicing mechanisms generating different isoforms, some of which lack the transmembrane domain and display antagonist properties to NRP1 full size (FS). NRP1 is further post-translationally modified by the addition of glycosaminoglycans (GAG) side chains through an O-glycosylation site at serine612. Here, we characterized a novel splice variant which has never been investigated, NRP1-Δ7, differing from the NRP1-FS by a deletion of 7 amino acids occurring two residues downstream of the O-glycosylation site. This short sequence contains two aspartic residues critical for efficient glycosylation. As expected, the high molecular weight products appearing as a smear in SDS-PAGE and reflecting the presence of GAG in NRP1-FS were undetectable in the NRP1-Δ7 protein. NRP1-Δ7 mRNA was found expressed at an appreciable level, between 10 and 30% of the total NRP1, by various cells lines and tissues from human and murine origin. To investigate the biological properties of this isoform, we generated prostatic (PC3) and breast (MDA-MB-231) cancer cells able to express recombinant NRP1-FS or NRP1-Δ7 in a doxycycline-inducible manner. Cells with increased expression of NRP1-Δ7 were characterized in vitro by a significant reduction of proliferation, migration and anchorage-independent growth, while NRP1-FS had the expected opposite “pro-tumoral” effects. Upon VEGF-A165 treatment, a lower internalization rate was observed for NRP1-Δ7 than for NRP1-FS. Finally, we showed that NRP1-Δ7 inhibited growth of prostatic tumors and their vascularization in vivo. This report identifies NRP1-Δ7 as a splice variant displaying anti-tumorigenic properties in vitro and in vivo, emphasizing the need to consider this isoform in future studies.
Research center :
Giga-Cancer - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Hendricks, Céline; University of Liège > Département des sciences biomédicales et précliniques > Laboratory of Connective Tissues Biology
Dubail, Johanne; Institut Imagine–Hôpital Necker-Enfants Malades, Paris, France
Brohée, Laura ; Université de Liège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs
Delforge, Yves ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs > Doct. sc. bioméd. & pharma. (Bologne)
Colige, Alain ✱; Université de Liège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs
Deroanne, Christophe ✱; Université de Liège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs
✱ These authors have contributed equally to this work.
Language :
English
Title :
A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo
Publication date :
31 October 2016
Journal title :
PLoS ONE
eISSN :
1932-6203
Publisher :
Public Library of Science, San Franscisco, United States - California
F.N.R.S-Télévie, #7.4544.13F (CH) and #7.4546.15 (LB); ARC - Actions de Recherches Concertées (#10/15-02 (YD)
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE] CAC - Centre anticancéreux près l'Université de Liège asbl [BE] ULiège - Université de Liège [BE] Télévie [BE]
Rossignol M., Gagnon M.L. and Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics. 2000; 70:211-22. doi:10.1006/geno.2000.6381 PMID: 11112349.
Prud'homme G.J. and Glinka Y. Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget. 2012; 3:921-39. 626 [pii]. PMID: 22948112. doi:10.18632/oncotarget.626
Cao S., Yaqoob U., Das A., Shergill U., Jagavelu K., Huebert R.C., et al. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010; 120:2379-94. doi:10.1172/JCI41203 PMID: 20577048.
Delcombel R., Janssen L, Vassy R., Gammons M., Haddad O., Richard B., et al. New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis. 2013; 16:353-71. doi:10.1007/s10456-012-9320-y PMID: 23254820.
Rizzolio S., Rabinowicz N., Rainero E., Lanzetti L, Serini G., Norman J., et al. Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Res. 2012; 72:5801-11. doi:10.1158/0008-5472.CAN12-0995 PMID: 22986738.
Soker S., Takashima S., Miao H.Q., Neufeld G. and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998; 92:735-45. PMID: 9529250.
West D.C., Rees CG, Duchesne L, Patey S.J., r C.J., Turnbull J.E., et al. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor2. J Biol Chem. 2005; 280:13457-64. doi:10.1074/jbc.M410924200 PMID: 15695515.
He Z. and Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997; 90:739-51. S0092-8674(00)80534-6 [pii] PMID: 9288753.
Valdembri D., Caswell P.T., Anderson K.I., Schwarz J.P., Konig I., Astanina E., et al. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol. 2009; 7:e25. doi:10.1371/journal.pbio.1000025 PMID: 19175293.
Frankel P., Pellet-Many C, Lehtolainen P., D'Abaco G.M., Tickner M.L., Cheng L, et al. Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Casmediated pathway. EMBO Rep. 2008; 9:983-9. doi:10.1038/embor.2008.151 PMID: 18704117.
Lindahl U. and Hook M. Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem. 1978; 47:385-417. doi:10.1146/annurev.bi.47.070178.002125 PMID: 354500.
Shintani Y., Takashima S., Asano Y., Kato H., Liao Y., Yamazaki S., et al. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 2006; 25:3045-55. [pii]. PMID: 16763549. doi:10.1038/sj.emboj.7601188
Yaqoob U., Cao S., Shergill U., Jagavelu K., Geng Z., Yin M., et al. Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res. 2012; 72:4047-59. doi:10.1158/0008-5472.CAN-11-3907 PMID: 22738912.
Parikh A A., Fan F., Liu W.B., Ahmad S.A., Stoeltzing O., Reinmuth N., et al. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol. 2004; 164:2139-51. doi:10.1016/S0002-9440(10)63772-8 PMID: 15161648.
Cackowski F.C., Xu L, Hu B. and Cheng S.Y. Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics. 2004; 84:82-94. doi:10.1016/j.ygeno.2004.02.001 S0888754304000382 [pii]. PMID: 15203206.
Gagnon M L, Bielenberg D.R., Gechtman Z., Miao H.Q., Takashima S., Soker S., et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Natl Acad Sci USA. 2000; 97:2573-8. doi:10.1073/pnas.040337597 PMID: 10688880.
Tao Q., Spring S.C. and Terman B.I. Characterization of a new alternatively spliced neuropilin-1 isoform. Angiogenesis. 2003; 6:39-45. 5141818 [pii]. PMID: 14517403.
Zhang L, David G. and Esko J.D. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J Biol Chem. 1995; 270:27127-35. PMID: 7592967.
Brohee L, Demine S., Willems J., Arnould T., Colige A.C. and Deroanne C.F. Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment. Oncotarget. 2015; 6:11264-80. 3595 [pii] doi: 10.18632/oncotarget.3595 PMID: 25834103.
Gabriel M., Delforge Y., Deward A., Habraken Y., Hennuy B., Piette J., et al. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis. BMC Cancer. 2015; 15:227. doi:10.1186/s12885-015-1259-0[pii]. PMID: 25884497.
Laboisse C.L., Augeron C. and Potet F. Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. Cancer Res. 1981; 41:310-5. PMID: 7448770.
Bachelder R E., Wendt M.A. and Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002; 62:7203-6. PMID: 12499259.
Luo M., Hou L, Li J., Shao S., Huang S., Meng D., et al. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kappaB and beta-catenin. Cancer Lett. 2016; 373:1-11. doi:10.1016/j.canlet.2016.01.010 PMID: 26805761.
Mak P., Leav I., Pursell B., Bae D., Yang X., Taglienti C.A., et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell. 2010; 17:319-32. doi:10.1016/j.ccr.2010.02.030 PMID: 20385358.
Hong T.M., Chen Y.L., Wu Y.Y., Yuan A., Chao Y.C., Chung Y.C., et al. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res. 2007; 13:4759-68. doi:10.1158/1078-0432.CCR-07-0001 PMID: 17699853.
Esko J.D. and Zhang L. Influence of core protein sequence on glycosaminoglycan assembly. Curr Opin Struct Biol. 1996; 6:663-70. S0959-440X(96)80034-0 [pii]. PMID: 8913690.
Fukasawa M., Matsushita A. and Korc M. Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther. 2007; 6:1173-80. 4363 [pii]. PMID: 17726369.
Nakayama M. and Berger P. Coordination of VEGF receptor trafficking and signaling by coreceptors. Exp Cell Res. 2013; 319:1340-7. doi:10.1016/j.yexcr.2013.03.008 PMID: 23499743.
Miao H.Q., Lee P., Lin H., Soker S. and Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 2000; 14:2532-9. doi:10.1096/fj.00-0250com PMID: 11099472.
